| scholarly article | Q13442814 |
| P2093 | author name string | C A Gorman | |
| D M Ilstrup | |||
| G B Bartley | |||
| V Fatourechi | |||
| S J Jacobsen | |||
| J A Garrity | |||
| E F Kadrmas | |||
| P2860 | cites work | UNILATERAL EXOPHTHALMOS WITH SPECIAL REFERENCE TO ENDOCRINE EXOPHTHALMOS AND PSEUDOTUMOR | Q76969151 |
| ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA | Q77059439 | ||
| RELATION BETWEEN MYASTHENIA GRAVIS AND THYROID DISEASE | Q77161943 | ||
| Hypertrophic osteoarthropathy and pretibial myxedema associated with Graves' disease | Q78383770 | ||
| Thyroid function and myasthenia gravis | Q78830319 | ||
| Involuntary Eye Movements in a Patient with Myasthenia and Hyperthyroidism | Q78938672 | ||
| Thyroid acropachy | Q79315301 | ||
| Asymmetric exophthalmos | Q80719918 | ||
| Evaluation of Exophthalmos | Q33977988 | ||
| Connective tissue, glycosaminoglycans, and diseases of the thyroid | Q38688493 | ||
| Diagnostic criteria for Graves' ophthalmopathy | Q40547417 | ||
| Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases | Q40814860 | ||
| Correlation of CT scanning and pathologic features of ophthalmic Graves' disease | Q41470422 | ||
| High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy | Q41942655 | ||
| Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods | Q45232711 | ||
| Endocrine exophthalmos. | Q48794594 | ||
| The treatment of Graves' ophthalmopathy in an incidence cohort. | Q51034070 | ||
| Pathogenesis and treatment of endocrine exophthalmos. | Q51316925 | ||
| Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. | Q51646069 | ||
| The Incidence of Graves' Ophthalmopathy in Olmsted County, Minnesota | Q57482586 | ||
| Prognostic factors in the radiotherapy of Graves' ophthalmopathy | Q68353384 | ||
| Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy | Q69058834 | ||
| Prevalence, natural history and surgical treatment of exophthalmos | Q69395891 | ||
| Positional effects on exophthalmometer readings in Graves' eye disease | Q69804394 | ||
| Upper eyelid retraction and Graves' disease | Q70170609 | ||
| Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease | Q70761049 | ||
| Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes | Q70763949 | ||
| Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy | Q71243280 | ||
| Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema | Q72922135 | ||
| The thyroid gland in relation to neuromuscular disease | Q73169808 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 284-90 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Clinical features of Graves' ophthalmopathy in an incidence cohort | |
| P478 | volume | 121 |
| Q47611270 | A Comparative Study of Full-Thickness Blepharotomy Versus Transconjunctival Eyelid Lengthening in the Correction of Upper Eyelid Retraction in Graves' Orbitopathy. |
| Q47635665 | A single transcutaneous injection with Botox for dysthyroid lid retraction. |
| Q49796061 | A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy. |
| Q38617832 | Advances in the management of thyroid eye diseases: An overview |
| Q38582072 | Age differences in clinical manifestation and prognosis of thyroid eye disease |
| Q74216803 | An ounce of prevention is worth a pound of cure? |
| Q36305798 | An overview of thyroid eye disease |
| Q33774785 | Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy |
| Q43222102 | Asymmetric graves ophthalmopathy as a sole manifestation of autoimmune hypothyroidism |
| Q46224055 | Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure |
| Q55272145 | Bovine Acellular Dermal Matrix for Levator Lengthening in Thyroid-Related Upper-Eyelid Retraction. |
| Q38727516 | Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease |
| Q89620715 | Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy |
| Q38586238 | Chylous Ascites: A Rare Adverse Effect of Methimazole Treatment for Grave's Disease-A Case Report and Review of the Literature |
| Q39158982 | Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions |
| Q55358395 | Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease. |
| Q59793763 | Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease |
| Q83074221 | Clinical features of pediatric Graves' orbitopathy |
| Q83001971 | Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves' orbitopathy |
| Q35179672 | Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease |
| Q39848782 | Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage |
| Q36319418 | Comparison of Efficacy and Complications Among Various Spacer Grafts in the Treatment of Lower Eyelid Retraction: A Systematic Review |
| Q34394088 | Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. |
| Q26776335 | Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review |
| Q41879308 | Double motion of upper eyelids in Graves' orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies |
| Q53594409 | Dysregulation of TNF/TNFR superfamily members: a systemic link between intra- and extrathyroidal manifestations in Graves' disease. |
| Q46835363 | Effect of smoking on retrobulbar blood flow in thyroid eye disease |
| Q94554835 | Etiologies of Proptosis: A review |
| Q90261097 | Extraocular muscle sampled volume in Graves' orbitopathy using 3-T fast spin-echo MRI with iterative decomposition of water and fat sequences |
| Q38218911 | Extrathyroidal manifestations of Graves' disease: a 2014 update |
| Q41505945 | Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient |
| Q34284248 | Graves' Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis |
| Q38607128 | Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature |
| Q35731002 | Graves' ophthalmopathy: a review of immunogenetics |
| Q54112051 | Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. |
| Q35542692 | Hyperthyroid vs hypothyroid eye disease: the same severity and activity |
| Q33789467 | Immunopathogenesis of thyroid eye disease: emerging paradigms |
| Q36069781 | Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt |
| Q59329543 | Intraoperative relaxed muscle positioning technique results in a tertiary Center for Thyroid Orbitopathy Related Strabismus |
| Q36359703 | Intravenous immunoglobulin in eye involvement |
| Q79954849 | Late presentation of severe thyroid eye disease |
| Q48875078 | Levator recession with adjustable sutures for correction of upper eyelid retraction in thyroid eye disease. |
| Q53084294 | Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. |
| Q58767088 | Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy |
| Q40994540 | Long-term follow-up of Graves ophthalmopathy in an incidence cohort |
| Q39570204 | Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy |
| Q44688138 | Lower lid retraction in thyroid orbitopathy: lamellar shortening or proptosis? |
| Q96219330 | Management of Thyroid Eye Disease-Related Strabismus |
| Q42291097 | Masquerading Orbital Sarcoidosis with Isolated Extraocular Muscle Involvement |
| Q38130235 | Medical management of thyroid eye disease |
| Q49059614 | Nodular Mucinosis in Graves Disease Mimicking Gouty Tophi |
| Q52624186 | Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye. |
| Q37682318 | Ocular surface effects of thyroid disease. |
| Q45711807 | Ophthalmic manifestations of endocrine disorders-endocrinology and the eye. |
| Q35544113 | Ophthalmological evaluation in thyroid‐associated ophthalmopathy |
| Q35589867 | Ophthalmopathy in childhood Graves' disease |
| Q35216491 | Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients |
| Q77567436 | Orbital computed tomographic characteristics of globe subluxation in thyroid orbitopathy |
| Q37026793 | Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy |
| Q34998187 | Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts |
| Q37715255 | Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India |
| Q41834085 | Primary hypothyroidism with infiltrative ophthalmopathy and dermopathy |
| Q73081478 | Pseudo-pseudotumor |
| Q34565430 | Quality of life in patients with Graves ophthalmopathy. |
| Q47121440 | RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy |
| Q37023968 | Rectus muscle resection in Graves' ophthalmopathy |
| Q28081573 | Rituximab in the Treatment of Thyroid Eye Disease: A Review |
| Q34369410 | Semiautomatic regional segmentation to measure orbital fat volumes in thyroid-associated ophthalmopathy. A validation study |
| Q37649883 | Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association |
| Q42919451 | The Role of Intravenous Methylprednisolone Immunosuppression in the Management of Active Thyroid Eye Disease |
| Q39303459 | The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy |
| Q53684503 | The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study. |
| Q36481829 | The graded levator hinge procedure for the correction of upper eyelid retraction (an American Ophthalmological Society thesis). |
| Q33876359 | The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy. |
| Q37781259 | The ocular surface in thyroid diseases |
| Q34871250 | The relationship between Graves' ophthalmopathy and dry eye syndrome |
| Q33895382 | The relationship between sex and symmetry in thyroid eye disease |
| Q91789199 | Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm |
| Q36981285 | Thyroid antibody-negative euthyroid Graves' ophthalmopathy |
| Q43007760 | Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression |
| Q35919247 | Thyroid associated orbitopathy. |
| Q90665142 | Thyroid autoantibodies in adults with acquired binocular diplopia of unknown origin |
| Q47445224 | Thyroid disease induced diplopia |
| Q86525873 | Thyroid eye disease |
| Q48818966 | Thyroid eye disease: a Southeast Asian experience. |
| Q45897216 | Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy. |
| Q55140443 | Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. |
| Q53743982 | Thyroid-associated Ophthalmopathy. |
| Q34147441 | Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management |
| Q33910021 | Thyroid-associated orbitopathy |
| Q47096983 | Thyroid-associated orbitopathy in patients with thyroid carcinoma: A case report of 5 cases |
| Q34525298 | Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis) |
| Q38367695 | Total thyroid ablation in Graves' orbitopathy |
| Q39287610 | Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease |
| Q85032350 | Treatment of Thyroid Eye Disease |
| Q49084302 | Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. |
| Q37406589 | Update on thyroid eye disease and management. |
| Q33758124 | What is the role of botulinum toxin in the treatment of dysthyroid strabismus? |
| Q84020983 | [Clinical and neuroradiological diagnostics in Graves' orbitopathy] |
| Q76384457 | [Endocrine orbit disorders. Pathogenesis, clinical presentation and examination, stage-dependent therapy] |
| Q74775419 | [Endocrine orbitopathy 1998] |
Search more.